Literature DB >> 8137487

Marked clinical improvement in patients with hepatocellular carcinoma by surgical removal of extended tumor mass in right atrium and pulmonary arteries.

N Masaki1, S Hayashi, T Maruyama, H Okabe, M Matsukawa, J Unno, S Maekawa, T Oka, M Tani, K Matsueda.   

Abstract

Two patients with advanced hepatocellular carcinoma presented severe exertional dyspnea because of extension of a tumor into the right side of the heart. Removable of the tumor thrombus by open-heart surgery ameliorated the symptoms in each case, but their subsequent courses differed considerably. One patient survived for as long as 8 months thanks to successive multi-disciplinary treatments, whereas the other patient died suddenly 1 month after the surgery. The first patient's hepatocellular carcinoma was more differentiated, and the dyspnea was caused by a low cardiac output due to the intracardiac tumor mass, not by pulmonary embolism as in the second patient's case. We conclude that successive multidisciplinary treatments to control the growth of hepatocellular carcinoma is the most important approach and is indispensable for improving the prognosis.

Entities:  

Mesh:

Year:  1994        PMID: 8137487     DOI: 10.1007/bf00686660

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  3 in total

1.  Effectiveness of chemoembolization therapy for metastatic right atrial tumor thrombus associated with hepatocellular carcinoma.

Authors:  Y Dazai; T Katoh; I Katoh; S Sueda; R Yoshida
Journal:  Chest       Date:  1989-08       Impact factor: 9.410

2.  Hepatocellular carcinoma with tumor thrombus extending into the right atrium: report of a successful resection with the use of cardiopulmonary bypass.

Authors:  M Fujisaki; E Kurihara; K Kikuchi; K Nishikawa; Y Uematsu
Journal:  Surgery       Date:  1991-02       Impact factor: 3.982

3.  Growth of hepatocellular carcinoma into the right atrium. Report of five cases.

Authors:  Y Kato; N Tanaka; K Kobayashi; T Ikeda; N Hattori; A Nonomura
Journal:  Ann Intern Med       Date:  1983-10       Impact factor: 25.391

  3 in total
  6 in total

Review 1.  Acute pulmonary embolism as the first manifestation of hepatocellular carcinoma complicated with tumor thrombi in the inferior vena cava: surgery or not?

Authors:  Hsuan-Hwai Lin; Chung-Bao Hsieh; Heng-Cheng Chu; Wei-Kuo Chang; You-Chen Chao; Tsai-Yuan Hsieh
Journal:  Dig Dis Sci       Date:  2007-03-15       Impact factor: 3.199

2.  Severe refractory congestive cardiac failure in an elderly man.

Authors:  B O'Neill; H Taggart
Journal:  Postgrad Med J       Date:  1997-05       Impact factor: 2.401

3.  Concomitant Hepatectomy and Atrial Thrombectomy under Cardiopulmonary Bypass versus Staged Hepatectomy in the Treatment for Hepatocellular Carcinoma with Large Right Atrial Tumor Thrombi.

Authors:  Wen-Shan Chao; Ching-Hui Shen; Shao-Ciao Luo; Feng-Hsu Wu; Hao-Ji Wei; Chu-Leng Yu; Cheng-Chung Wu; Yun Yen; Fang-Ku P'eng
Journal:  J Clin Med       Date:  2022-04-12       Impact factor: 4.964

Review 4.  Syncope as the initial presentation of pulmonary embolism in two patients with hepatocellular carcinoma: Two case reports and literature review.

Authors:  Dayong Deng; Haidi Wu; Huafang Wei; Zikai Song; Yang Yu; Chongyin Zhang; Lei Yang
Journal:  Medicine (Baltimore)       Date:  2021-09-24       Impact factor: 1.817

5.  Hepatocellular Carcinoma With Tumor Thrombus Occupying the Right Atrium and Portal Vein: A Case Report and Literature Review.

Authors:  Xin Luo; Binhao Zhang; Shuilin Dong; Bixiang Zhang; Xiaoping Chen
Journal:  Medicine (Baltimore)       Date:  2015-08       Impact factor: 1.817

6.  Hepatocellular carcinoma on cirrhosis complicated with tumoral thrombi extended to the right atrium: results in three cases treated with major hepatectomy and thrombectomy under hypothermic cardiocirculatory arrest and literature review.

Authors:  Benedetta Pesi; Francesco Giudici; Luca Moraldi; Gianfranco Montesi; Stefano Romagnoli; Fulvio Pinelli; Pierluigi Stefano; Giacomo Batignani
Journal:  World J Surg Oncol       Date:  2016-03-12       Impact factor: 2.754

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.